Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
162 studies found for:    Open Studies | "Aggression"
Show Display Options
Rank Status Study
21 Unknown  The Affect of Orthodontic Treatment on the Periodontal Status of Patients With Aggressive Periodontitis
Condition: Aggressive Periodontitis
Intervention: Procedure: orthodontic treatment
22 Not yet recruiting Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Conditions: Relapsed and Refractory Aggressive B- and T-cell Lymphomas;   Lymphoma
Interventions: Drug: volasertib;   Drug: belinostat
23 Recruiting A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
Condition: Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
Interventions: Drug: lipegfilgrastim;   Drug: pegfilgrastim
24 Unknown  Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans
Conditions: Dementia;   Pain
Intervention: Behavioral: Preventing Aggression in Veterans with Dementia (PAVeD)
25 Recruiting Diet an Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation
Condition: Psychiatric Hospitalization
Intervention: Dietary Supplement: Orthica Soft Multi Mini and Orthica Fish EPA Mini
26 Recruiting Using Emotion Regulation to Decrease Aggression in Veterans With PTSD
Condition: Chronic Post-Traumatic Stress Disorder
Intervention: Behavioral: Manage Emotions to Reduce Aggression (MERA)
27 Recruiting Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression
Condition: Traumatic Brain Injury
Interventions: Drug: Buspirone;   Drug: Placebo
28 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
29 Unknown  Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Quetiapine XR
30 Recruiting Evaluation of a Brief Surf the Urge Intervention
Conditions: Substance Use;   Deliberate Self-harm;   Trichotillomania;   Aggression;   Stealing;   Eating Pathology;   Gambling
Intervention: Behavioral: Surf the Urge
31 Not yet recruiting Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control
Conditions: Aggression;   Self-Injurious Behavior
Intervention: Behavioral: Functional Communication Training
32 Unknown  Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Valproate;   Drug: Risperidone;   Drug: Placebo;   Drug: Stimulant medication;   Behavioral: Behavioral family counseling
33 Recruiting Predictors of Suicidal Behavior in Depression
Conditions: Suicidal Behavior;   Depression;   Traumatic Events;   Impulsivity Aggression
Intervention: Other: Standardized assessment on depressed patients
34 Recruiting Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Conditions: Aggressive Non-Hodgkin Lymphoma;   Myelodysplastic/Myeloproliferative Neoplasm;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Aggressive Adult Non-Hodgkin Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Hodgkin Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Plasma Cell Myeloma;   Waldenstrom Macroglobulinemia
Interventions: Drug: Atorvastatin Calcium;   Drug: Cyclosporine;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Peripheral Blood Stem Cell Transplantation;   Radiation: Total-Body Irradiation
35 Recruiting OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
Condition: CD20+ Aggressive B-Cell Lymphoma
Interventions: Drug: Conventional Vincristine;   Drug: Liposomal Vincristine;   Drug: Ricover-scheme rituximab;   Drug: optimised rituximab-schedule
36 Recruiting Preventing Sexual Aggression Among High School Boys
Condition: Violence
Intervention: Behavioral: Your Voice Your View
37 Recruiting Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer
Conditions: Symptomatic, Aggressive, Sporadic, Unresectable, Locally;   Advanced/Metastatic Medullary Thyroid Cancer (MTC)
Intervention: Drug: Vandetanib 300 mg
38 Recruiting Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741;   Drug: Placebo
39 Recruiting A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumors;   Aggressive Systemic Mastocytosis;   Advanced Cancers
Intervention: Drug: DCC-2618
40 Recruiting KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: KPT-330;   Drug: Rituximab;   Drug: Etoposide;   Drug: Carboplatin;   Drug: Ifosfamide;   Drug: Dexamethasone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years